MGDII Health Innovation, Commercialization and Entrepreneurship Fellowship Program Class of 2020
The Michael G. DeGroote Health Innovation, Commercialization and Entrepreneurship (MGDII Health ICE) initiative is pleased to announce its first class of fellows.
The Michael G. DeGroote Health Innovation, Commercialization and Entrepreneurship (MGDII Health ICE) initiative is pleased to announce its first class of fellows.
“I expect that this group of young scientists will help bridge the gap between traditional research and research that leads to commercialization,” said Dr. John Kelton, Executive Director, Michael G. DeGroote Initiative for Innovation in Healthcare (MGDII).
The MGDII Health ICE Fellowship Program helps postdoctoral fellows develop entrepreneurial and commercialization skills while immersed in McMaster University’s cutting-edge research landscape.
“These fellows, their supervisors, members of the MGDII College of Health Inventors, and many others are starting to change the culture at McMaster,” added Dr. Kelton.
The inaugural members of the MGDII Health ICE Fellowship Program are Blessing Bassey, Tseegii (Battsetseg) Batchuluun, Maria Eugenia Davola, Steven Gameiro, Reza (Mohammadreza) Heydarian, Karim Soliman, and Milica Vukmorivic.
Learn more about each MGDII Health ICE fellow below.
Blessing Bassey, PhD
Blessing has a PhD degree in genetics and molecular biology from McMaster University. Her research focuses on how lung, breast and melanoma cancers spread to the brain. Her goal is to contribute to the cure for metastatic cancer.
Tseegii (Battsetseg) Batchuluun, MD PhD
Tseegii is a postdoctoral fellow in the Steinberg Lab at McMaster University. Prior, she practiced internal and emergency medicine in Mongolia and Japan. Her research focuses on the development of metabolic diseases to find new therapies.
Maria Eugenia Davola, PhD
Maria completed a PhD in organic chemistry and molecular virology at the University of Buenos Aires. In 2016, she became a postdoctoral fellow in the Mossman Lab at McMaster University. She leads studies that use viruses to recognize and kill human cancer cells.
Steven Gameiro, PhD
Steven completed a PhD in microbiology and immunology at The University of Western Ontario. He currently works with Dr. Brian Lichty in the Department of Pathology and Molecular Medicine. Steven is working towards therapies that treat cancer and infectious diseases.
Reza (Mohammadreza) Heydarian, PhD
As a PhD candidate, Reza developed AI methods to process abdominal MRI and chest CT scans. He currently studies machine learning, evolutionary algorithms, bio-signal analysis, and medical image processing.
Karim Soliman, PhD
Karim holds a PhD in pharmaceutics. He has been part of several academic and pharmaceutical industry projects extending over the areas of ocular, oral, topical, and transdermal drug delivery. His current interests involve the controlled delivery of small molecule drugs and biologics to the anterior and posterior segments of the eye.
Milica Vukmorivic, PhD
Milica received a PhD in life sciences from the University of Lausanne. She won the Blavatnik Fellowship for Entrepreneurship in Life Sciences from Yale University. Currently, Milica is an Innovation and Commercialization Consultant at the St. Joseph’s Research Institute. She works on translational research and commercialization projects surrounding lung diseases.
Related News
News Listing
Two Faculty of Health Sciences cancer researchers awarded Canada Research Chairs
Dept. Biochem, Dept. Surgery, Feature, Research
June 27, 2024
Elena Verdu appointed director of Farncombe Family Digestive Health Research Institute
Faculty & Staff, Research
June 27, 2024